N. Fleury-Brégeot, A. Panossian, A. Chiaroni, A. Marinetti
FULL PAPER
the thermodynamically favoured anti,anti isomer 1aЈ has been ob-
tained as the major product. Phosphanes 1a and 1aЈ have been
purified by column chromatography under argon.
(CHCp), 71.1 (CHCp), 71.2 (CHCp), 83.1 (CCp), 126.8, 126.9, 127.6,
128.1, 128.2, 129.7, 129.8, 131.1, 132.4, 132.5 (CHPh), 136.5 (CPh
)
ppm. 31P NMR (CDCl3): δ = 51 ppm. MS (MALDI): m/z (%) =
472.1 (100) [M – BH3].
To obtain the borane complexes 3a or 3aЈ, the crude product iso-
lated from the reaction above after removal of acetic acid was dis-
solved in THF. An excess of BH3·THF adduct (1.6 mL, 1 solu-
tion in THF) was added at room temperature. After evaporation
of the solvent, the final product was purified by column chromatog-
raphy.
(S)-1-Ferrocenylpentan-1-ol (4a):[24] A solution of borane–dimethyl
sulfide complex (1.0 mL, 10 mmol) in anhydrous THF (about
10 mL) was prepared under argon. A fifth of this solution (2.2 mL)
was added to a solution of (R)-2-methyl-CBS-oxazaborolidine in
toluene (1 , 3.0 mL, 3.0 mmol) under argon. The remaining BH3–
Me2S solution and a solution of pentanoylferrocene (2.70 g,
10.0 mmol) in THF (10 mL) under argon were added simulta-
neously to this mixture at 0 °C. The addition was carried out over
about 60 min. The mixture was stirred for another 60 min at 0 °C,
then quenched by dropwise addition of methanol (2 mL) and satd.
aqueous NH4Cl (8 mL). The aqueous layer was extracted with di-
ethyl ether. The organic phases were combined, washed with water
and brine, and dried with magnesium sulfate. Purification by col-
umn chromatography (eluent: heptane/ethyl acetate, 5:1) gave (S)-
1-ferrocenylpentan-1-ol as an amber-orange oil. Yield: 2.51 g
anti,syn-1,2,3-Triphenyl-2-phospha[3]ferrocenophane (1a): Complex
1a was purified by column chromatography on silica gel with hex-
ane/ethyl acetate (90:10) as the eluent (Rf = 0.5). It was obtained
1
as an orange solid in 68% yield (160 mg). H NMR (CDCl3): δ =
4.00 (d, JH,P = 12.5 Hz, 1 H, CHPh), 4.09 (d, JH,P = 5.0 Hz, 1 H,
CHPh), 4.13 (m, 1 H, Cp), 4.14 (m, 1 H, Cp), 4.15 (m, 1 H, Cp),
4.18 (m, 1 H, Cp), 4.22 (m, 1 H, Cp), 4.29 (m, 1 H, Cp), 4.34 (m,
1 H, Cp), 4.41 (m, 1 H, Cp), 6.80 (t, 2 H), 6.95 (4 H), 7.06 (4 H),
7.21 (3 H), 7.39 (d, J = 7.5 Hz, 2 H) ppm. 13C NMR (CDCl3): δ
1
1
= 35.9 (d, JP,C = 18.6 Hz, PCH), 44.8 (d, JP,C = 24.0 Hz, PCH),
68.1 (CHCp), 68.3 (CHCp), 68.5 (d, JP,C = 6.3 Hz, CHCp), 68.8
(CHCp), 69.1 (CHCp), 69.5 (d, JP,C = 9.2 Hz, CHCp), 69.7 (CHCp),
1
(92%). H NMR (CDCl3): δ = 0.92 (t, JH,H = 7.0 Hz, 3 H, Me),
3
1.3–1.5 (m, 4 H, CH2), 1.6–1.7 (m, 2 H, CH2), 1.94 (d, JH,H
=
3.5 Hz, 1 H, OH), 4.2 (m, 3 H, CHCp), 4.23 (s, 5 H, Cp), 4.27 (1
H, CHCp), 4.33 (m, 1 H, CHOH) ppm. HPLC [Chiralpak AD; n-
hexane/isopropyl alcohol, 98:2, 1 mL/min; tR/min = 17.2 (R), 23.7
(S)]: ee = 98%. [α]D = +45 (c = 1, CHCl3).
1
70.4 (d, JP,C = 4.2 Hz, CHCp), 85.5 (d, JP,C = 7.4 Hz, CCp), 87.3
(d, JP,C = 15.5 Hz, CCp), 126.0, 126.1, 127.2, 127.3, 127.6, 128.3,
1
1
128.6, 128.7, 128.8, 133.2, 133.3, 134.5 (d, JP,C = 20.5 Hz, CPh),
137.5 (d, 2JP,C = 6.6 Hz, CPh), 141.4 (d, JP,C = 14.4 Hz, CPh) ppm.
2
31P NMR (CDCl3): δ = 26 ppm. MS (MALDI): m/z (%) = 472.1
(100) [M]. HRMS: calcd. for C30H26FeP [M + H] 473.1099; found
473.1122.
(S)-(α-Ferrocenylpentyl)diisobutylphosphane (5a): Diisobutylphos-
phane (4 mL) in hexane (10 wt.-% solution, about 1.8 mmol) was
added to
a degassed solution of (S)-1-ferrocenylpentan-1-ol
(275 mg, 1.0 mmol) in degassed acetic acid (10 mL) under argon.
The mixture was stirred overnight under argon at room tempera-
ture. The solvent and the remaining diisobutylphosphane were
evaporated under vacuum. The residue was purified by chromatog-
raphy on a short silica gel column, under argon. Elution with hep-
tane/ethyl acetate (5:1) gave (S)-(1-ferrocenylpentyl)diisobutylphos-
phane as an amber-coloured oil. Yield: 360 mg (90%). 31P NMR
(CDCl3): δ = –28 ppm. HRMS: calcd. for C23H38FeP [M + H]
401.2041; found 401.2061. [α]D = –39 (c = 0.1, CHCl3); ee = 98%.
NMR characterisation has been performed on the corresponding
borane complex, 5a·BH3: 1H NMR (CDCl3): δ = 0.92 (d, 3J =
6.6 Hz, 3 H, Me), 0.95 (d, 3J = 6.6 Hz, 3 H, Me), 1.03 (t, 3 H, Me),
1.04 (d, 3J = 6.9 Hz, 6 H, Me), 1.2–1.7 (7 H, CH2, CH), 1.8–2.1 (5
H, CH2, CH), 2.50 (ddd, J = 8.1, J = 6.6, J = 4.5 Hz, 1 H, CHP),
3.97 (1 H, CHCp), 4.08 (1 H, CHCp), 4.19 (s, 5 H, Cp), 4.2 (2 H,
CHCp) ppm. 13C NMR (CDCl3): δ = 14.0 (Me), 23.0 (CH2), 24.0,
Borane Complex of anti,syn-1,2,3-Triphenyl-2-phospha[3]ferroceno-
phane (3a): Column chromatography was performed with hexane/
ethyl acetate, 80:20 (Rf = 0.4) to afford 3a as a yellow-orange solid.
1H NMR (CDCl3): δ = 4.19 (m, 1 H, Cp), 4.21 (d, JH,P = 4.7 Hz,
1 H, CHPh), 4.24 (m, 1 H, Cp), 4.28 (m, 1 H, Cp), 4.34 (m, 1 H,
Cp), 4.37 (m, 2 H, Cp), 4.46 (d, JH,P = 18.3 Hz, 1 H, CHPh), 5.19
(m, 2 H, Cp), 6.9–7.2 (13 H, Ph), 7.50 (2 H, Ph) ppm. 13C NMR
1
1
(CDCl3): δ = 34.0 (d, JP,C = 27.3 Hz, PCH), 46.7 (d, JP,C
=
26.3 Hz, PCH), 68.3 (CHCp), 68.4 (CHCp), 70.4 (CHCp), 70.5
(CHCp), 70.7 (CHCp), 71.0 (CHCp), 71.1 (CHCp), 81.7 (CCp), 83.8
(CCp), 127.1, 127.4, 127.5, 128.1, 129.6, 130.0, 130.1, 130.4, 132.3,
132.4 (CHPh), 136.6 (CPh) ppm. 31P NMR (CDCl3): δ = 55 ppm.
HRMS (MALDI): calcd. for C30H25FeP [M – BH3] 472.1043;
found 472.1031.
anti,anti-1,2,3-Triphenyl-2-phospha[3]ferrocenophane (1aЈ): Com-
plex 1a was purified by column chromatography on silica gel with
hexane/ethyl acetate (90:10) as the eluent (Rf = 0.5). It was obtained
in 60% yield (70 mg, starting from 0.25 mmol of 2a) as an orange
24.3, 24.6 (d, JP,C = 2.0 Hz), 24.7 (d, JP,C = 1.0 Hz), 25.1 (d, JP,C
=
1
7.5 Hz), 25.3 (d, JP,C = 7.8 Hz), 31.1 (d, JP,C = 30.1 Hz, PCH2),
1
31.4 (d, JP,C = 3.5 Hz, CH2), 32.7 (d, JP,C = 30.3 Hz, PCH2), 33.1
1
solid. H NMR (CDCl3): δ = 4.05 (d, JH,P = 6.0 Hz, 2 H, CHPh),
1
(d, JP,C = 3.5 Hz, CH2), 36.0 (d, JP,C = 26.9 Hz, PCH), 66.9
4.08 (m, 2 H, Cp), 4.26 (m, 2 H, Cp), 4.33 (m, 2 H, Cp), 4.88 (m,
(CHCp), 67.2 (CHCp), 67.9 (CHCp), 68.7 (CHCp), 69.0 (Cp), 88.7
(d, JP,C = 4.1 Hz, CCp) ppm. 31P NMR (CDCl3): δ = 23 ppm. [α]D
= –35 (c = 0.1, CHCl3). The enantiomeric excess of 5a was deter-
mined by HPLC analysis of the corresponding oxide, which was
prepared as follows: (S)-(1-ferrocenylpentyl)diisobutylphosphane
(100 mg, 0.25 mmol) was dissolved in acetone (about 2 mL), and
hydrogen peroxide (35 wt.-% solution in water) was added. The
mixture was stirred overnight at room temp. After addition of
water, the aqueous phase was extracted with dichloromethane. The
organic layer was washed with brine, dried with magnesium sulfate
and concentrated to give (S)-(1-ferrocenylpentyl)diisobutylphos-
2 H, Cp), 6.9 (t, 2 H), 7.0–7.1 (6 H), 7.2 (4 H), 7.2–7.3 (4 H) ppm.
1
13C NMR (CDCl3): δ = 48.7 (d, JP,C = 15.8 Hz, PCH), 67.8, 68.7
(d, JP,C = 7.2 Hz, Cp), 69.8, 70.2 (d, JP,C = 3.9 Hz, Cp), 86.8 (d,
1JP,C = 12.8 Hz, CCp), 125.9, 127.6, 127.7, 128.1, 128.2, 129.0,
1
133.0, 133.3 (CHPh), 135.9 (d, JC,P = 16.0 Hz, PCPh), 141.5 (d,
2JC,P = 11.4 Hz, CPh) ppm. 31P NMR (CDCl3): δ = 21 ppm.
Borane Complex of anti,anti-1,2,3-Triphenyl-2-phospha[3]ferroceno-
phane (3aЈ): Column chromatography was performed with hexane/
ethyl acetate (80:20) (Rf = 0.4) to afford 150 mg of 3aЈ (63% yield)
as a yellow-orange solid. 1H NMR (CDCl3): δ = 4.08 (m, 2 H, Cp),
4.19 (d, JH,P = 17.7 Hz, 2 H, CHPh), 4.20 (m, 2 H, Cp), 4.29 (m,
1
phane oxide as a red-brown oil. H NMR (CDCl3): δ = 0.98–1.07
2 H, Cp), 5.17 (m, 2 H, Cp), 6.9–7.0 (6 H, Ph), 7.1 (4 H, Ph), 7.1– (15 H, Me), 1.3–2.1 (12 H, CH2, CH), 2.71 (ddd, J = 16.2, J = 6.6,
7.33 (3 H, Ph), 7.55 (t, 2 H, Ph) ppm. 13C NMR (selected data,
CDCl3): δ = 45.8 (d, JP,C = 29.1 Hz, PCH), 68.6 (CHCp), 70.9
J = 4.5 Hz, 1 H, CHP), 4.01 (1 H, CHCp), 4.16 (2 H, CHCp), 4.17
1
(s, 5 H, Cp), 4.22 (1 H, CHCp) ppm. 13C NMR (CDCl3): δ = 14.0
3858
www.eurjic.org
© 2007 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Eur. J. Inorg. Chem. 2007, 3853–3862